NCT03136679 · COMPLETED
Discovery of Novel Biomarkers That Will Lead to the Early Detection of Alzheimer's Disease
This study is collecting blood and urine samples from people with varying degrees of cognitive impairment to search for new biological markers that might detect Alzheimer's earlier. Researchers are also looking at B-vitamin levels to see if they connect to those markers. This is an observational study, not a drug trial — no treatment is being tested, and nothing here is proven or approved.
Eligibility criteria
Inclusion Criteria: A. Both Males and females B. Patients at least 40-years of age C. Mild Cognitive Impairment D. Alzheimer 's disease 1. Mild 2. Moderate 3. Severe Exclusion Criteria: A. No recent major surgery within the last 6 months B. Free of any malignant disease C. No chronic renal disease D. No other major neurodegenerative disorders (i.e. Parkinson's disease, multiple sclerosis)
The sponsor's own eligibility wording, lightly reformatted. The study team makes the final eligibility decision — worth discussing with your doctor.
Eligibility criteria as of 2026-01-26